News | October 04, 2024
Lilly invests US$ 4.5 billion to create advanced research and manufacturing site
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Stable profits, low leverage to keep credit profiles comfortable
Fluoxetine Tabs 60 mg approval solidifies the company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules
ALS patients experience neuroinflammation and rapid neurodegeneration
More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
Subscribe To Our Newsletter & Stay Updated
